- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Study Highlights Lower Uterine Segment Thickness as Key Predictor for Uterine Rupture Risk During TOLAC
Canada: A recent secondary analysis of the PRISMA cluster randomized trial has shed new light on the role of lower uterine segment thickness (LUST) in predicting the risk of uterine rupture during the trial of labor after cesarean (TOLAC). The study, which focused on third-trimester measurements, highlights the potential of LUST as a key indicator for assessing uterine rupture risk, offering valuable insights for obstetric care.
The research published in the American Journal of Obstetrics & Gynecology MFM found that a LUST measurement between 2.0 and 2.4 mm in the third trimester was associated with a low risk of uterine rupture in women attempting TOLAC under specific conditions. However, the study also revealed that women with LUST measurements between 2.5 and 3.0 mm, who did not meet these special conditions had a higher incidence of uterine rupture.
These findings suggest that the current threshold for safe TOLAC might need to be adjusted, potentially extending the definition to include women with LUST measurements under 3.0 mm.
The study also found that LUST measurements greater than or equal to 3.0 mm, when combined with both vaginal and abdominal ultrasound, were associated with an exceptionally low risk of uterine rupture.
Third-trimester lower uterine segment thickness has been linked to the risk of uterine rupture during trial of labor after cesarean, with threshold values differing depending on the type of ultrasound used—lower values with vaginal ultrasound and higher values with abdominal ultrasound. Given this variability, Emmanuel Bujold, Department of Obstetrics and Gynecology, Faculty of Medicine, Université Laval, Québec, Canada, and colleagues sought to determine the optimal LUST cut-off value by combining both vaginal and abdominal ultrasound measurements to more accurately predict uterine rupture during TOLAC.
For this purpose, the researchers conducted a secondary analysis of the PRISMA cluster randomized trial, which included women with a single previous cesarean who underwent LUST measurement at 34-38 weeks. The thinnest measurement was obtained by combining transvaginal and transabdominal ultrasounds. Participants were categorized into three LUST risk groups: ≥2.5 mm (low risk, TOLAC safe), 2.0-2.4 mm (intermediate risk, TOLAC safe under specific conditions), and <2.0 mm (high risk for uterine rupture).
Delivery outcomes, including uterine rupture, were analyzed using non-parametric methods and receiver operating characteristics (ROC) curves.
The key findings of the study were as follows:
- Among 3,460 participants, 81% were classified as low-risk, 11% as intermediate-risk, and 8% as high-risk for uterine rupture.
- Low-risk participants were more likely to attempt TOLAC (49%) and undergo labor induction (16%) compared to intermediate-risk (46% and 12%) and high-risk participants (13% and 3%).
- Four cases of uterine rupture occurred during TOLAC among 1,382 low-risk participants, but there were no uterine ruptures in intermediate-risk (0/178) or high-risk (0/35) groups.
- In low-risk participants, uterine rupture was strongly associated with LUST measurements (vaginal + abdominal ultrasound), with an area under the ROC curve of 0.93.
- All uterine rupture cases occurred in women with a LUST between 2.5 and 3.0 mm (4/371, 1.1%), while no ruptures occurred in those with LUST ≥3.0 mm (0/1,011).
"We emphasize the critical importance of using a combined transabdominal and transvaginal approach for LUST measurement, supported by both extensive literature and the findings of this study," the researchers wrote.
"A large-scale study utilizing these new parameters could potentially show a reduction in uterine ruptures during TOLAC," they concluded.
Reference:
Bujold, E., Dubé, E., Girard, M., & Chaillet, N. (2024). Lower uterine segment thickness to predict uterine rupture: A secondary analysis of PRISMA cluster randomized trial. American Journal of Obstetrics & Gynecology MFM, 101543. https://doi.org/10.1016/j.ajogmf.2024.101543
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751